Upstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology Congress highlighting the advantages of verekitug, a treatment targeting the TSLP receptor, over tezepelumab, ...

Our models help scientists predict the results of new and currently impossible experiments to move their science forward much ...

The AI models, which are built on massive datasets and can be adapted to multiple tasks, have become a part of medtech ...

In the rapidly evolving field of computational intelligence, there is a pressing demand for advanced tools and algorithms ...

New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior ...

Bio Protocol enables researchers and patients to launch BioAgents - autonomous AI co-scientists that generate hypotheses, fund experiments and mo ...

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, ...

Bio Protocol raises $6.9M in seed funding led by Arthur Hayes’ Maelstrom Fund to expand its decentralised science initiatives ...